AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 72 filers reported holding AMYLYX PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,759,892 | -63.0% | 696,881 | -56.4% | 0.03% | -65.8% |
| Q2 2023 | $34,487,259 | +179.3% | 1,598,853 | +279.9% | 0.08% | +145.2% |
| Q1 2023 | $12,347,475 | -48.2% | 420,841 | -34.8% | 0.03% | -52.3% |
| Q4 2022 | $23,853,183 | +342.9% | 645,553 | +237.4% | 0.06% | +282.4% |
| Q3 2022 | $5,386,000 | +566.6% | 191,334 | +204.1% | 0.02% | +466.7% |
| Q1 2022 | $808,000 | – | 62,915 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,088,333 | $224,963,904 | 6.32% |
| Alpha Wave Global, LP | 821,220 | $30,344,079 | 5.54% |
| Ghost Tree Capital, LLC | 350,000 | $12,933,000 | 5.52% |
| Boxer Capital, LLC | 2,084,000 | $77,003,800 | 4.06% |
| Altium Capital Management LP | 140,000 | $5,173,000 | 2.63% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,693,000 | $99,506,350 | 2.06% |
| Iron Triangle Partners LP | 240,240 | $8,876,868 | 1.59% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 655,015 | $24,202,804 | 1.50% |
| EMERALD ADVISERS, LLC | 836,909 | $30,923,788 | 1.49% |
| GREAT POINT PARTNERS LLC | 190,000 | $7,020,500 | 1.38% |